CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Effect of Cytarabine, Melphalan, and Total Body Irradiation as Conditioning for Autologous Stem Cell Transplantation for Patients with AML in First Remission

Ki Mun Kang, Byung Ock Choi, Gyu Young Chai, Young Nam Kang, Hong Sek Jang, Hee Jae Kim, Wo Sung Min, Chun Choo Kim, Ihl Bohng Choi

Radiation Oncology Journal. 2003;21(3):192-198.

Total-Body Irradiation in the Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoproliferative Diseases

Cynthia Aristei, Antonio Tabilio

The Oncologist. 1999;4(5):386-397

Link1 Link2 Link3

Link4

Busulfan/Melphalan/Fludarabine (Bu/Mel/Flu) Conditioning Versus Total Body Irradiation/Thiotepa/Cyclophosphamide (HFTBI/Thio/Cy) Based Conditioning in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing CD34-Selected T-Cell Depleted Allogeneic Stem Cell Transplantation (alloSCT)

Jennifer S. Orozco, Patrick Hilden, Molly A. Maloy, Jeremy Pappacena, Larry W. Buie, Brian C. Shaffer, Esperanza B. Papadopoulos, Ann A. Jakubowski, Valkal Bhatt

Biology of Blood and Marrow Transplantation. 2019;25(3):S276-S277

Link1 Link2

Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma

Sigal Grisariu, Michael Y. Shapira, Reuven Or, Batia Avni

Clinical Lymphoma Myeloma and Leukemia. 2018;18(4):272-279

Link1 Link2

Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia

Takehiko Mori, Yoshinobu Aisa, Jun Kato, Akiko Yamane, Tomonori Nakazato, Naoyuki Shigematsu, Shinichiro Okamoto

American Journal of Hematology. 2012;87(4):349-353

Link1 Link2

Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation

Cecilie Blimark, Ljupco Veskovski, Jan Westin, Stig Rödjer, Mats Brune, Martin Hjorth, Erik Holmberg, Per-Ola Andersson, Ulf-Henrik Mellqvist

European Journal of Haematology. 2011;87(2):117-122

Link1 Link2

Melphalan and Total-Body Irradiation (MEL-TBI) is an Effective Conditioning Regimen for Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients With Very Poor-Risk Refractory Hematologic Malignancies

G. Akpek, D. Marangoz, C. Ilyas, V. Akbulut, B. Bhatnagar, K. Ruehle, A.Z. Badros, S. Yanovich, A.P. Rapoport

Biology of Blood and Marrow Transplantation. 2011;17(2):S318-S319

Link1 Link2

Outcomes of Fludarabine, Melphalan and Total Body Irradiation as a Reduced Intensity Conditioning Regimen in Matched Donor Allogeneic Peripheral Blood Stem Cell Transplantation

Dipenkumar Modi, Jie Chi, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti

Transplantation and Cellular Therapy. 2021;27(8):665.e1-665.e7

Link1 Link2

24. Total body irradiation, fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies

D. Petropoulos

Biology of Blood and Marrow Transplantation. 2005;11(11):937-938

Link1 Link2

Erratum: The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total body irradiation

R Burt, K Kallunian, D Patel, J Thomas

Bone Marrow Transplantation. 2004;35(1):105-105

Link1 Link2

Link3

Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabine and total body irradiation as a conditioning for hematopoietic stem cell transplantation

Takehiko Mori, Jun Kato, Akiko Yamane, Yoshinobu Aisa, Yusuke Kawata, Mayu Ichimura, Chiaki Tsuneyama, Tomoko Yashima, Yoko Ogawa, Kazuo Tsubota, Naoyuki Shigematsu, Takayuki Shimizu, Shinichiro Okamoto

International Journal of Hematology. 2011;94(3):261-265

Link1

Link2 Link3 Link4

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.